Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington’s, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease

被引:0
作者
Fumiaki Mori
Kunikazu Tanji
Yasuko Toyoshima
Mari Yoshida
Akiyoshi Kakita
Hitoshi Takahashi
Koichi Wakabayashi
机构
[1] Hirosaki University Graduate School of Medicine,Department of Neuropathology, Institute of Brain Science
[2] University of Niigata,Department of Pathology, Brain Research Institute
[3] Aichi Medical University,Department of Neuropathology
[4] University of Niigata,Department of Pathological Neuroscience, Center for Bioresource
来源
Acta Neuropathologica | 2012年 / 123卷
关键词
Amyotrophic Lateral Sclerosis; Multiple System Atrophy; Polyglutamine; Cytoplasmic Inclusion; Spinocerebellar Ataxia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:747 / 749
页数:2
相关论文
共 37 条
[1]  
De Marco N(2006)Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus J Biol Chem 281 16147-16156
[2]  
Buono M(2011)Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders Acta Neuropathol 121 519-527
[3]  
Troise F(2011)Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease Acta Neuropathol 121 555-557
[4]  
Diez-Roux G(2010)Mutations of optineurin in amyotrophic lateral sclerosis Nature 465 223-226
[5]  
Hortobagyi T(2012)Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington’s disease Neuroscience 202 363-370
[6]  
Troakes C(2011)Optineurin in neurodegenerative diseases Neuropathology 31 569-574
[7]  
Nishimura AL(2012)Optineurin in Huntington’s disease intranuclear inclusions Neurosci Lett 506 149-154
[8]  
Ito H(2012)Optineurin is colocalized with ubiquitin in Marinesco bodies Acta Neuropathol 123 289-292
[9]  
Fujita K(2010)Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling J Biosci 35 501-505
[10]  
Nakamura M(2010)Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going? J Mol Cell Biol 2 180-191